This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third Look: Discussing aficamten for patients with obstructive hypertrophic cardiomyopathy (oHCM) in the phase 3 SEQOUIA-HCM trial

Ticker(s): CYTK

Who's the expert?

Institution: RWJBH System

  • Cardiologist who manages 4 or 5 patients daily with heart failure
  • Research interest in nuclear and non-invasive cardiology. Dual fellowship training in Cardiology and Immunology/HIV

Interview Goal
oHCM

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.